Bonafide Women’s Health Acquires SAM-e Formulation With High Bioavailability
Executive Summary
Women’s health company acquired patent for SAM-e formulation MSI-195 after innovator's study showed it had nearly three times higher availability than a leading competitor.
You may also be interested in...
Research Bonafides, Detailing Gynecologists Included In Pharmavite's Third Women’s Health Line
“This acquisition, plus our existing women's health brands of Equelle and Uqora, positions us, the combined group, as the leader in women's health in nutraceuticals in the US,” says Pharmavite CEO Jeff Boutelle. Bonafide markets supplements for long-term, sustainable support for needs that compound with age, including hot flashes, vaginal dryness, vaginal microbiome and sexual satisfaction.
Pharmavite, GNC Launching SAM-e Dietary Supplement For Joints/Mood
Pharmavite and General Nutrition are introducing dietary supplements containing S-adenosylmethionine, a naturally occurring compound said to improve mood and help joints stay supple. BASF supplies the compound to Pharmavite and GNC; the raw material is produced in Italy.
It’s Been Over 1100 Days Since MCIT, Still No TCET In Sight
AdvaMed’s new online clock documents the time since CMS promised to replace MCIT, a program guaranteeing coverage for FDA-cleared breakthrough devices.